McCormack A - Search Results

1

Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.

Losa M, Mazza E, Terreni MR, McCormack A, Gill AJ, Motta M, Cangi MG, Talarico A, Mortini P, Reni M. Losa M, et al. Among authors: mccormack a. Eur J Endocrinol. 2010 Dec;163(6):843-51. doi: 10.1530/EJE-10-0629. Epub 2010 Sep 24. Eur J Endocrinol. 2010. PMID: 20870708

2

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours.

McCormack AI, McDonald KL, Gill AJ, Clark SJ, Burt MG, Campbell KA, Braund WJ, Little NS, Cook RJ, Grossman AB, Robinson BG, Clifton-Bligh RJ. McCormack AI, et al. Clin Endocrinol (Oxf). 2009 Aug;71(2):226-33. doi: 10.1111/j.1365-2265.2008.03487.x. Epub 2008 Dec 3. Clin Endocrinol (Oxf). 2009. PMID: 19067722

3

Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.

McCormack AI, Wass JA, Grossman AB. McCormack AI, et al. Eur J Clin Invest. 2011 Oct;41(10):1133-48. doi: 10.1111/j.1365-2362.2011.02520.x. Epub 2011 Apr 18. Eur J Clin Invest. 2011. PMID: 21496012

4

MGMT expression and pituitary tumours: relationship to tumour biology.

McCormack A, Kaplan W, Gill AJ, Little N, Cook R, Robinson B, Clifton-Bligh R. McCormack A, et al. Pituitary. 2013 Jun;16(2):208-19. doi: 10.1007/s11102-012-0406-8. Pituitary. 2013. PMID: 22797801

5

Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours.

De Sousa SMC, McCabe MJ, Wu K, Roscioli T, Gayevskiy V, Brook K, Rawlings L, Scott HS, Thompson TJ, Earls P, Gill AJ, Cowley MJ, Dinger ME, McCormack AI. De Sousa SMC, et al. Eur J Endocrinol. 2017 May;176(5):635-644. doi: 10.1530/EJE-16-0944. Epub 2017 Feb 20. Eur J Endocrinol. 2017. PMID: 28220018

6

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.

McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, Burman P; ESE survey collaborators. McCormack A, et al. Eur J Endocrinol. 2018 Mar;178(3):265-276. doi: 10.1530/EJE-17-0933. Epub 2018 Jan 12. Eur J Endocrinol. 2018. PMID: 29330228

7

Consensus on diagnosis and management of Cushing's disease: a guideline update.

Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Kelly DF, Lacroix A, McCormack A, Melmed S, Molitch M, Mortini P, Newell-Price J, Nieman L, Pereira AM, Petersenn S, Pivonello R, Raff H, Reincke M, Salvatori R, Scaroni C, Shimon I, Stratakis CA, Swearingen B, Tabarin A, Takahashi Y, Theodoropoulou M, Tsagarakis S, Valassi E, Varlamov EV, Vila G, Wass J, Webb SM, Zatelli MC, Biller BMK. Fleseriu M, et al. Among authors: mccormack a. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7. Epub 2021 Oct 20. Lancet Diabetes Endocrinol. 2021. PMID: 34687601 Free PMC article. Review.

8

MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.

Seabrook A, Wijewardene A, De Sousa S, Wong T, Sheriff N, Gill AJ, Iyer R, Field M, Luxford C, Clifton-Bligh R, McCormack A, Tucker K. Seabrook A, et al. Among authors: mccormack a. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2339-2349. doi: 10.1210/clinem/dgac162. J Clin Endocrinol Metab. 2022. PMID: 35323929 Free PMC article.

9

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients.

Burman P, Trouillas J, Losa M, McCormack A, Petersenn S, Popovic V, Theodoropoulou M, Raverot G, Dekkers OM; ESE survey collaborators †. Burman P, et al. Among authors: mccormack a. Eur J Endocrinol. 2022 Sep 19;187(4):593-605. doi: 10.1530/EJE-22-0440. Print 2022 Oct 1. Eur J Endocrinol. 2022. PMID: 36018781 Free PMC article.

10

Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question.

Trouillas J, Burman P, Losa M, McCormack A, Petersenn S, Popovic V, Theodoropoulou M, Dekkers OM, Raverot G. Trouillas J, et al. Among authors: mccormack a. Eur J Endocrinol. 2023 Apr 5;188(4):C5-C8. doi: 10.1093/ejendo/lvad042. Eur J Endocrinol. 2023. PMID: 36952293 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

311 results

Search Page